Effect of Shotblocker in Reducing Intramuscular Injection Pain in Adult Patients

NCT06624761 · tracked via the Priya Life Science Turkey tracker

Sponsor

Yağmur SÜRMELİ

Phase

Not applicable

Started

2024-10-14

Last updated

2024-10-03

Condition(s) studied

Patients Above 18 Years

Investigational drug(s) / intervention(s)

ShotBlocker

ShotBlocker: A randomized study investigating ShotBlocker in painkillers containing different active ingredients could not be found.

Study summary

This randomized, double-blind study aimed to determine the effect of ShotBlocker on IMI pain in adult patients who received diclofenac sodium and metamizole sodium as IMI in the emergency department. The main question(s) it aims to answer are as follows:

• \[Is there a difference between the pain score averages between the intervention group and the control group after ShotBlocker? Participants \[Participants in both groups are individuals who applied to the emergency department and received IM injections according to the doctor\'s order.\] If there is a comparison group: Researchers will make a comparison with the control group.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients aged 18 and over who speak Turkish, * Who have signed the informed consent form, * Who are admitted to the emergency room for prescription drug use or who are planned to use diclofenac sodium and metamizole sodium as IMI upon the directive of the emergency room physician will constitute. Exclusion Criteria: * Pregnant women, * Those with psychiatric disorders, * Those with hearing or vision problems, * Those who applied to the red area of the emergency room, * Those with impaired consciousness, * Those with secondary injuries and infections at the injection site, * Those who have previously received an injection at the same site within the last 24 hours, -Those who did not sign the informed consent form for the study

Primary outcome measure(s)

Visual Analog Scale (VAS) — 12 week.
The Visual Analog Scale (VAS) is used to measure the pain perceived by the person. In this scale, the individual can indicate their own pain by drawing a line, putting a dot, or pointing between the 10 cm (100 mm) section of the ruler where there is no pain (zero) on one end and the most severe pain on the other end. The distance from the point where there is no pain to the point marked by the individual is measured in centimeters and the value found indicates the individual\'s pain intensity. On the VAS scale, 0-44 mm indicates mild pain, 45-74 mm indicates moderate pain, and 75-100 mm reflects severe pain.

Trial sites (1)

Facility	City	Region	Status
Toros State Hospital	Mersin	Adana, Mersin

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06624761 on ClinicalTrials.gov ↗ ← All trials in Turkey